Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 3.250
+0.020 (0.62%)
Sep 2, 2026, 10:54 AM AEST
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 262.42 million as of September 1, 2026. Its market cap has decreased by -37.88% in one year.
Market Cap
262.42M
Enterprise Value
225.62M
Revenue
383.68M
Ranking
n/a
PE Ratio
11.92
Stock Price
3.25
ChartMarket Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 262.42M, an increase of 474.74%. That is a compound annual growth rate of 9.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 262.42M | 3.86% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.53B |
| Sigma Healthcare | 30.94B |
| Pro Medicus | 18.96B |
| Ramsay Health Care | 11.86B |
| Monash IVF Group | 274.69M |
| Paragon Care | 227.60M |
| BLS Pharmaceuticals | 211.58M |
| EBR Systems | 207.17M |